China's appetite for acquiring overseas companies was dealt a major setback this week as regulatory fears hindered two potential takeovers. How will this affect the $44bn ChemChina deal to acquire Swiss agribusiness Syngenta and other large-scale deals? US M&A correspondent James Fontanella-Khan explains.

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.